Andy Hu

Andy Hu is an accomplished professional in the biopharma industry, currently serving as Chief Business Officer at Augustine Therapeutics since January 2025. Prior to this role, Andy operated as an Independent Biopharma Business/Corporate Development Advisor starting May 2024 and held the position of Chief Business Officer at Manifold Bio for a brief period in early 2024, as well as at Arkuda Therapeutics from March 2019 to March 2024. Andy's expertise includes negotiation and relationship development, complemented by experience as a Biopharma BD/Strategy Consultant at ATH Advisory from October 2017 to March 2019. Andy holds an MD from Baylor College of Medicine and an MBA in Finance and Strategy from Rice Business.